Miyake M. Editorial Comment to Association of oncological response between the first-line
chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with
unresectable or metastatic urothelial carcinoma. Int J Urol 2022;29:364-365.
PMID: 35028986